Affordable Access

Publisher Website

Novel Approaches to Therapy of Hypereosinophilic Syndromes

Authors
Journal
Immunology and Allergy Clinics of North America
0889-8561
Publisher
Elsevier
Publication Date
Volume
27
Issue
3
Identifiers
DOI: 10.1016/j.iac.2007.07.003
Disciplines
  • Biology
  • Medicine
  • Pharmacology

Abstract

There has been recent progress in the understanding of the pathogenesis of the hypereosinophilic syndromes (HES). This led to the distinction of subgroups, in which the underlying cause has been identified. Consequently, new treatment options became available, such as imatinib and mepolizumab, which proved to be promising. This article summarizes these new pharmacologic approaches to the therapy of HES.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Novel approaches to therapy of hypereosinophilic s...

on Immunology and allergy clinics... August 2007

Novel therapies for hypereosinophilic syndromes.

on The Netherlands journal of med... August 2010

Approach to the therapy of hypereosinophilic syndr...

on Immunology and allergy clinics... August 2007

Approach to the Therapy of Hypereosinophilic Syndr...

on Immunology and Allergy Clinics... Jan 01, 2007
More articles like this..